Essais liés3clinical trials
VilleMeridianlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Import ClinicalTrials.gov

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Dihydroergotamine Migraine Phase 3 NCT03901482 EMERGE — A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine COMPLETED
Dihydroergotamine Migraine Phase 3 NCT04406649 ASCEND — A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine COMPLETED
Dihydroergotamine Migraine Phase 3 NCT04940390 SUMMIT — A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine COMPLETED